Tirzepatide is a synthetic dual GIP and GLP-1 receptor agonist studied for its effects on incretin signaling, glucose metabolism, insulin response, and broader metabolic regulation.
This product is supplied strictly for laboratory and scientific research purposes only. It is not intended for human consumption, medical treatment, diagnostic use, or veterinary applications. Purchasers are responsible for ensuring compliance with all applicable laws and regulations regarding the handling and use of research materials.
Tirzepatide is an acylated peptide engineered to activate both the glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Research has examined its receptor signaling characteristics, cAMP-related activity, insulin and glucagon regulation, metabolic signaling, and the structural interactions responsible for its dual-receptor activity.
For a research-use-only catalog, Tirzepatide is suitable for research involving:
Purity: ≥98%